The mortality rate for ovary malignant neoplasms in Japan is projected to increase gradually from 4.95 thousand female deaths in 2024 to 5.06 thousand in 2028. This represents a steady year-on-year growth ranging from 0.61% to 0.60%. Previously, in 2023, the mortality was slightly below 4.95 thousand female deaths, indicating a consistent upward trend. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is estimated to be approximately 0.55%, reflecting a moderate and continual increase in mortality rates.

Future trends to watch for:

Potential advancements in early detection and treatment methods that could alter future mortality trends.
The impact of public health initiatives focused on prevention and awareness of ovarian cancer.
Demographic changes, particularly aging populations, which might influence mortality rates over time.